-
-
-
-
-
-
-
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
-
-
-
-
-
-
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
-
-
-
-
-
-
Raymond James Starts ADMA Biologics (ADMA) at Outperform
-
-
-
-
-
-
-
ADMA Biologics (ADMA) June 10 and 15 calls active, share price down 18.4%
-
-
-
-
-
-
-
ADMA Biologics reports $510-511 million 2025 revenue, raises 2026 outlook
-
-
-
-
-
-
-
ADMA Biologics (ADMA) spreader of 3K contracts of April 19 and May 22 calls as share price up 4.3%
-
-
-
-
-
-
-
ADMA Biologics (ADMA) PT Raised to $28 at Mizuho
-
430,619 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

